# New York Blood Center National Cord Blood Program

> **NCT00212407** · EARLY_PHASE1 · TERMINATED · sponsor: **New York Blood Center** · enrollment: 4476 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Genetic Disease
- Severe Aplastic Anemia
- Myelodysplasia

## Interventions

- **BIOLOGICAL:** Umbilical Cord Blood Transplantation

## Key facts

- **NCT ID:** NCT00212407
- **Lead sponsor:** New York Blood Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1993-02
- **Primary completion:** 2011-11-10
- **Final completion:** 2011-11-10
- **Target enrollment:** 4476 (ACTUAL)
- **Why stopped:** Study NCT01656603 supersedes this study; FDA IND 6637
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212407, "New York Blood Center National Cord Blood Program". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00212407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*